Table 2

CML/CLL/ALL Case Description (n = 9)

Age at dx

Disease stage at dx

Chemotherapy

Radiation

Leukemia Type

Time from breast dx to leukemia (months)

Time from leukemia

dx to last fu (months)


79

I

none

yes

CLL

37

57 (Alive)


64

I

none

yes

CLL

61

56 (Dec.)


74

I

none

yes

CLL

96

20 (Alive)


61

II

None

no

CLL

79

109 (Alive)


58

I

None

yes

CLL

110

70 (Alive)


50

I

recurrence 1993

yes

CML

33

9 (Dec.)


73*

I

None

yes

CML

3

14 (Dec.)


76

II

None

yes

ALL

38

19 (Dec.)


81

I

None

yes

ALL

81

4 (Dec.)


* Cytogenetics: Philadelphia chromosome resulting from a 9;22 translocation designated as 46, XX, t(9;22)(q34;q11 2).

Kaplan et al. BMC Cancer 2011 11:260   doi:10.1186/1471-2407-11-260

Open Data